about
Beta-amyloid deposition in chronic traumatic encephalopathyPathologic correlates of dementia in individuals with Lewy body disease.Neurodegeneration across stages of cognitive decline in Parkinson disease.Cognitive dysfunction and depression in Parkinson's disease: what can be learned from rodent models?An update on brain imaging in parkinsonian dementiaRelationship and factor structure in multisystem neurodegeneration in Parkinson's disease.Neocortex and allocortex respond differentially to cellular stress in vitro and aging in vivoThe microtubule-stabilizing agent, epothilone D, reduces axonal dysfunction, neurotoxicity, cognitive deficits, and Alzheimer-like pathology in an interventional study with aged tau transgenic mice.Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process.Presence of Striatal Amyloid Plaques in Parkinson's Disease Dementia Predicts Concomitant Alzheimer's Disease: Usefulness for Amyloid Imaging.Potential for misdiagnosis in community-acquired PET scans for dementia.Gait speed in Parkinson disease correlates with cholinergic degenerationDysfunction of the Default Mode Network in Drug-Naïve Parkinson's Disease with Mild Cognitive Impairments: A Resting-State fMRI Study.Effects of dual tasks and dual-task training on postural stability: a systematic review and meta-analysis.Milestones in Parkinson's disease--clinical and pathologic features.Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts.Mild cognitive impairment in Parkinson disease: heterogenous mechanisms.Neurobiology of cognitive impairment in Parkinson's disease.Mild cognitive impairment in Parkinson's disease.Executive dysfunction in Parkinson's disease: a review.The pathomechanisms underlying Parkinson's disease.The impact of silent vascular brain burden in cognitive impairment in Parkinson's disease.Neuropathobiology of non-motor symptoms in Parkinson disease.Molecular Imaging and Updated Diagnostic Criteria in Lewy Body Dementias.Nonmotor Symptoms in Parkinson Disease: A Descriptive Review on Social Cognition Ability.Mild cognitive impairment in Parkinson's disease: a distinct clinical entity?Disturbed sleep in Parkinson's disease: anatomical and pathological correlates.α-Synuclein staging in the amygdala of a Parkinson's disease model: cell types involved.The relationship between motor symptom lateralization and cognitive performance in newly diagnosed drug-naïve patients with Parkinson's disease.Treadmill Training with Cues and Feedback Improves Gait in People with More Advanced Parkinson's Disease.Critical appraisal of pathology transmission in the α-synuclein fibril model of Lewy body disorders.The catecholaminergic innervation of the claustrum of the pig.Recent advances in cholinergic imaging and cognitive decline-Revisiting the cholinergic hypothesis of dementia.
P2860
Q28385330-BD7D8780-8B55-406B-A0EE-7E082F5BB061Q33896668-A8AF093B-CC97-4558-92FE-F0FDB74DB6C8Q34096712-E79E249D-A7A0-414A-8388-D1F4141D2A85Q34307633-23C0BFEE-7CCE-49C7-B8BF-B11ECC01849AQ34327937-833581E4-8087-430F-B191-5B65B97FAEA9Q34401518-5F5F4F51-A783-4401-88DA-10BC7FF82777Q34639246-41ADB57F-55A1-4FCB-A53E-D40896F6E51CQ35875920-226AC043-83C5-4CD3-AC56-BA03637F5600Q36175217-3E103E35-DF92-4301-B1C2-40B4F755A19DQ36178474-EAA42662-C8D0-4DB3-8F38-748F747B009BQ37207582-6BFF967C-7585-4696-94C5-340FB0792A3FQ37251657-83626DB8-22C1-406C-AFA2-5F7A3ED42094Q37366136-CB44DFE6-1371-44FA-8D46-AA6E8B7414AFQ37723114-E5CCB83E-F6A3-4A21-AD64-EA33E210471BQ37882587-7BD4E494-FEF8-4B9C-AA4E-CFFA76D5C25CQ37955871-5113D7BB-2966-4BDC-B229-DB19E2E332DDQ37986572-FB57B62F-2F6F-4AC8-9900-C47C8B77D2C7Q38067143-C6A6B8C6-5776-4986-ACAC-DB98CF37069FQ38090986-91369D73-F378-4017-96DD-B97320EE6B6DQ38134409-F4491470-9C3B-4616-9DFF-D4ABEFD47C62Q38182660-FBD07305-9D05-4B7E-A6C6-F62FAAA4545AQ38475592-6E17F92E-D730-4B5E-8A63-7922F71BD36FQ38481481-C30A1D13-86C9-4A8F-903F-257712B8C2F3Q38642389-5B529071-8E7E-4366-81BD-907ADE517522Q39028811-51EE0C1C-E82B-49D4-ACC1-2D518AF28548Q41152157-B42DAD3C-9775-41A6-AF50-E03A22766710Q43728140-E70B28D5-E4D6-48E0-8022-5D2E63871752Q44281222-6F282F0D-DA10-4EF6-848B-1704F984414EQ45841445-ECEA9D69-2F8E-4A1A-91E4-F93AE8780962Q47381109-500FA913-1691-4ED1-908C-C6AE8D409235Q47619917-E00427D3-A75E-45E4-9C6F-B942C169840BQ48088844-B0E9AC05-5052-4658-B623-95FCDCB485E4Q50420909-53A14C4B-0E0D-48A4-A510-06B2707CF61F
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The morbid anatomy of dementia in Parkinson's disease.
@en
The morbid anatomy of dementia in Parkinson's disease.
@nl
type
label
The morbid anatomy of dementia in Parkinson's disease.
@en
The morbid anatomy of dementia in Parkinson's disease.
@nl
prefLabel
The morbid anatomy of dementia in Parkinson's disease.
@en
The morbid anatomy of dementia in Parkinson's disease.
@nl
P2860
P1476
The morbid anatomy of dementia in Parkinson's disease.
@en
P2093
Michail E Kalaitzakis
Ronald K B Pearce
P2860
P2888
P304
P356
10.1007/S00401-009-0597-X
P577
2009-10-10T00:00:00Z